Transjugular intrahepatic portosystemic shunt in liver transplant recipients

Table 1 Summary of clinical data and outcomes

Patientno.	Age,sex	Cause of liver disease	Transplant pathology before TIPS	Indication for TIPS	MELD score at TIPS	CPC at TIPS	Time from transplantation to TIPS (mo)	Encephalopathypost-TIPS	Follow-up after TIPS
1	71, F	Hepatitis C	HCV recurrence	Ascites	22	C	15	Yes	Died 1 mo
2	59, M	Hepatitis C	HCV recurrence	Ascites	26	C	16	Yes	Died 3 mo
3	37, F	Primary biliary cirrhosis	Vanishing bile duct syndrome	Ascites	18	B	4	Yes	Died 4 mo
4	56, M	Hepatitis C	HCV recurrence	Ascites	15	C	158	Yes	ReLT 8 mo, died after ReLT, see below
	59, M	Hepatitis C	HCV recurrence	Ascites	13	C	18	Yes	TIPS reduction day 11 and 16; died at 2 mo
5	52, M	Fatty liver cirrhosis	Vanishing bile duct syndrome	Ascites	35	C	10	No	ReLT 3 mo; alive 32 mo
6	51, F	Hepatitis C	HCV recurrence	Ascites	19	B	61	No	Died 3 mo
7	71, M	Primary biliary cirrhosis	Thrombosis of the portal vein at the anastomosis	Ascites	12		4	No	TIPS revision 3 mo; died 12 mo
8	62, M	Hemochromatosis	Vanishing bile duct syndrome	Hydrothorax	21	C	17	Yes	Died 1.5 mo
9	68, M	Fatty liver cirrhosis	Vanishing bile duct syndrome	Hydrothorax/Ascites	30	B	11	Yes	Died 11 d
10	38, F	Autoimmune hepatitis	Vanishing bile duct syndrome + thrombosis of the portal vein	Bleeding	1	B	8	Yes	TIPS reduction 2.5 mo; died 19 mo

¹MELD score calculation not possible due to incomplete laboratory data. ReLT: Liver retransplantation.